Would you favor oral bisphosphonates over intravenous formulations for patients with hormone sensitive prostate cancer and androgen deprivation therapy (ADT) related osteopenia?
Community PollStarted
Do you favor oral bisphosphonates over intravenous formulations for patients with hormone sensitive prostate cancer and androgen deprivation therapy (ADT) related osteopenia?
43 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Endocrinology · MGH
Answered on
If kidney function is normal, either would do. Therapy depends on the risk level. (See Cosman et al., PMID 39073912.)
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Endocrinology · University of Missouri School of Medicine
Answered on
If tolerated, oral bisphosphonates are effective and usually first choice. ALSO THE CHEAPEST.
Join for free or sign in to see the full answer